Viewing Study NCT04608032


Ignite Creation Date: 2025-12-24 @ 9:26 PM
Ignite Modification Date: 2025-12-26 @ 5:06 PM
Study NCT ID: NCT04608032
Status: RECRUITING
Last Update Posted: 2024-02-09
First Post: 2020-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia
Sponsor: Centre hospitalier de Ville-Evrard, France
Organization:

Study Overview

Official Title: Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia
Status: RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NARCIS
Brief Summary: This study evaluates the effect of a cognitive remediation program on neurocognitive, social cognitive and metacognitive functions designed for patients living with a schizophrenia spectrum disorder.
Detailed Description: Evaluation of the specific therapeutic efficacy of the ecological cognitive remediation program for schizophrenia spectrum disorder \[ECo-Sz\] on neurocognitive deficits, social cognition deficits and metacognition deficits of patients with a schizophrenia spectrum disorder.

In this double-blind (patients, outcomes assessors) controlled randomized trial the investigators compare patients receiving Ecological Cognitive training program for schizophrenia spectrum disorder \[ECo-Sz\] to patients benefiting from recovery-oriented therapy \[ThOR\]. Patients are treated for two months and monitored for four months.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: